Alexandria Venture Investments
About
Key facts
- Portfolio companies
- 16
- Stages
- Series ASeries B
- Cheque size
- $30M to $215M
Recent investments
| Date | Company | Round | Amount |
|---|---|---|---|
| 13 Aug 2026 | Khartis Therapeutics, Inc. | Series B | $50M |
| 27 Feb 2025 | Tahoe Therapeutics | Series A | $30M |
| 23 May 2024 | Elysian | Undisclosed round | $31M |
| 27 May 2020 | Insitro | Series B | $143M |
| 31 May 2018 | Insitro | Series A | $100M |
| 10 Aug 2015 | Editas Medicine | Series B | $120M |
3 reviews from Reddit gathered in one place
https://app.dealroom.co/investors/alexandria_venture_investments
Participants include Johnson & Johnson Innovation - JJDC, Inc. (JJDC); Adjuvant Capital, an impact investment fund supported by the Bill & Melinda Gates Foundation as an anchor investor, Serum Institute of India; Alexandria Venture Investme…
Participants include Johnson & Johnson Innovation - JJDC, Inc. (JJDC); Adjuvant Capital, an impact investment fund supported by the Bill & Melinda Gates Foundation as an anchor investor; Serum Institute of India; Alexandria Venture Investme…
Each quote is copied word for word and links to where it was posted. Promotion and off-topic posts are filtered out.
Frequently asked
What companies has Alexandria Venture Investments invested in?
Alexandria Venture Investments has invested in Khartis Therapeutics, Inc., Tahoe Therapeutics, Elysian, Insitro, Editas Medicine and 11 more.
SEC filings, insider activity, nonprofit links and pay benchmarks for Alexandria Venture Investments:
